RT Journal Article
SR Electronic
T1 Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 43
OP 47
VO 63
IS 1
A2 Hoffman, Gary S.
A1 Wikenheiser, Kathryn A.
A1 Silberstein, Edward B.
YR 1996
UL http://www.ccjm.org/content/63/1/43.abstract
AB SUMMARY It is recommended that routine bone scans not be adopted for follow-up of patients with stage I—II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.